Cite Filings / SPRO / 0001193125-23-227646

Feed Companies Filings Check

Sign in

ARS

Annual Report to Security Holders

Spero Therapeutics, Inc. Filed 2023-09-01 Acc 0001193125-23-227646

Documents 1

ARS Annual Report to Security Holders , d539138dars.pdf

Around this filing

2024-04-16 ARS Annual Report to Security Holders
2023-09-01 ARS Annual Report to Security Holders
2023-09-01 DEF 14A Proxy Statement
2023-08-30 4 Chief Development Officer sold 1,854 shares at $1.26 ($2,336)
2023-08-30 4 Chief Legal Officer sold 1,854 shares at $1.26 ($2,336)
2023-08-30 4 Director sold 9,040 shares at $1.26 ($11,390)
2023-08-30 4 CEO and President sold 6,017 shares at an average $1.29 ($7,748)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d539138dars.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…